Literature DB >> 11180042

An alternative hypothesis to involvement of intestinal P-glycoprotein as the cause for digoxin oral bioavailability enhancement by talinolol.

W L Chiou, C Ma, S M Chung, T C Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11180042

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  3 in total

Review 1.  Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.

Authors:  Joseph D Ma; Shirley M Tsunoda; Joseph S Bertino; Meghana Trivedi; Keola K Beale; Anne N Nafziger
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

2.  pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.

Authors:  Sibylle Neuhoff; Anna-Lena Ungell; Ismael Zamora; Per Artursson
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

3.  Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly Water-Soluble Talinolol: Preparation, in vitro and in vivo Assessment.

Authors:  Mohsin Kazi; Mohammed Al-Swairi; Ajaz Ahmad; Mohammad Raish; Fars K Alanazi; Mohamed M Badran; Azmat Ali Khan; Amer M Alanazi; Muhammad Delwar Hussain
Journal:  Front Pharmacol       Date:  2019-05-02       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.